Quite some time ago, you posted that Takeda financially loses should AFFY declare BK. Since I know that is not true (as a matter of fact I explained Takeda actually financially gains from an AFFY BK), I asked you to explain how much financially Takeda stood to lose and why. Of course, you did not and could not answer my question to support your false assertion.
Here we are again. I have said that the value of AFFY's bare legal title to the O patents, after AFFY sold Takeda 100% exclusive worldwide license to commercialize O, is miniscule. As R. Reagan would say, Here you go again. You have accused my statement about AFFY's title to the O patent as being a lie. Since you claim to have almost a Ph D in finance and to teach finance at Stern Business School, please point out on AFFY's balance sheet where it discloses the value of its intellectual property, namely its patents to O. You cannot and will not because it has little to no financial value.
Indeed, the true value of AFFY's bare legal title to O's patent is so minimal, that even AFFY knows it will not spend any money to defend it in litigation. Here is AFFY's disclosure from its 10Q on the topic:
Our receipt of potential royalties and milestone payments associated with OMONTYS is based on the strength of the exclusive license to Takeda under our proprietary rights. WE ARE DEPENDENT TO A LARGE EXTENT ON TAKEDA TO PROTECT OUR PROPRIETARY RIGHTS AS WE HAVE GIVEN TAKEDA CONTROL IN THE FIRST INSTANCE OVER SUCH RIGHTS, AND WE MAY NOT BE ABLE TO ENSURE THEIR PROTECTION.
Bottom line: Takeda owns and controls O and O's proprietary rights, too. That is the result of Takeda owning an exclusive 100% worldwide license to market O. AFFY's patent right to O is but "bare legal title" which is an empty shell, just like AFFY.
I will ask you the question again, Maxdad, and do not reply that you have answered it countless times, because you have never answered it. The simple fact remains that Takeda, in fact, benefits from an AFFY bankruptcy as I have already explained in one of my earlier posts. You have the floor, Professor, this student wants to know how Takeda loses financially from an AFFY bankruptcy as you have earlier instructed your followers.
GWP...You're right still again...ABOUT "THERE YOU GO AGAIN"...LYING and DISTORTING, TWISTING AND CONTORTING SHREDS OF INFORMATION like LAWYERS LIKE YOU SEEM TO DO. AND which is what you do relentlessly here in your now thousands of posts.
TAKEDA DOES IN FACT CONTROL OMONTYS which is not only fine with me but most people who know the true story since very few of us have much regard for Affymax's former management (and I'll admit apparently neither did Takeda...Which is why they brought in The Brenner Group...YUP, you can argue all you want that it was AFFYMAX that did that, and yes it is a contract between TBG and Affymax, but I know for a FACT that this was at the insistence of Takeda and I will NEVER reveal to you or anyone else how I know that...It is none of your business)...Choose to ignore or reject that...I really could care less!!!
As a Shell Company they wrote down the value of their IP as they wrote down ALL their assets before they were disposed by TBG. Which as you well know doesn't mean anything in terms of the true value of their assets... AFFYMAX's IP value now rests with THE AMENDED AGREEMENT which you clearly have IGNORED and I'm sure that's been totally conscious on your part since you have NEVER EVER acknowledged that that is EXACTLY WHERE THE VALUE OF AFFY REMAINS...In the PAYMENTS FROM TAKEDA for MILESTONE ACHIEVEMENTS AND PERPETUAL ROYALTIES...THIS IS FUNDAMENTAL TO YOUR DECEPTION and I KNOW YOU KNOW THIS...If you don't then you're an even bigger fool than I and most of the people here take you for!!!
IF YOU REALLY DO STILL HOLD A HEFTY SHORT POSITION YOUR POSTS HERE WILL NOT PROTECT YOU FROM THE INEVITABLE RESTORATION OF OMONTYS...Again YOU HAVE FAILED TO CITE ONE DRUG EVER that had similar mortality stats that was NOT either kept or returned to the market...AND AS LAWYERS ARE PRONE TO SAY....................CASE CLOSED!!!
Well Maxdad.. If Takeda did not have confidence in the previous Affy management, then how come Orwin has been re-appointed as Chairman whereas Takeda could have recommended any other person that has more credibility..
Or is it your opinion that Orwin is the best among the previous Affy management ?
Hey GWP.. we all know the track record of Maxdad in QCOR.. Can you give us an example from other stocks where you have been giving advice to investors in the past and how it turned out.
ymc, this is NOT a bash, it contains public, factual information from which GWP draws conclusions and requests rebuttal. It is a valid post and should be addressed as such. Personnally Im interested in the answer because AFFY is bascially a tossup right now (as even MAXDAD agrees) and Im just trying to discern whether the coin has "more weight" on one side vs the other.